UniCredit SpA
LSE:0RLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
UniCredit SpA
LSE:0RLS
|
IT |
|
N
|
NN Group NV
OTC:NNGRY
|
NL |
|
C
|
Corcept Therapeutics Inc
XMUN:HTD
|
US |
|
C
|
Cardinal Health Inc
XBER:CLH
|
US |
Wall St Price Targets
0RLS Price Targets Summary
UniCredit SpA
According to Wall Street analysts, the average 1-year price target for 0RLS is 82.116 EUR with a low forecast of 67.807 EUR and a high forecast of 94.691 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RLS's stock price target?
Price Target
82.116
EUR
According to Wall Street analysts, the average 1-year price target for 0RLS is 82.116 EUR with a low forecast of 67.807 EUR and a high forecast of 94.691 EUR.
What is the Revenue forecast for UniCredit SpA?
Projected CAGR
-3%
Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 5 years is -3%.
What is the Net Income forecast for UniCredit SpA?
Projected CAGR
6%
The compound annual growth rate for Net Income over the next 5 years is 6%.
